Xcell Biosciences Funding: $17M Raised, Series B (2022)
Xcell Biosciences is based in San Francisco. It has raised $17M in total funding. Latest round: Series B.
Xcell Biosciences funding overview
Xcell Biosciences is based in San Francisco. Xcell Biosciences has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Xcell Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Casdin Capital, Dynamk Capital, Formic Ventures, Labcorp, HBM Genomics, Viking Global Investors. 6 distinct backers are named across the disclosed rounds.
Xcell Biosciences has raised $17M in total disclosed funding across the rounds on record.
Who has invested in Xcell Biosciences?
Casdin Capital, Dynamk Capital, Formic Ventures, Labcorp, HBM Genomics, Viking Global Investors are named among the investors backing Xcell Biosciences.
What was the latest Xcell Biosciences funding round?
The most recent disclosed round is a Series B, announced in January 2022.
Where is Xcell Biosciences based?
Xcell Biosciences is based in San Francisco.
When did Xcell Biosciences last raise?
The last disclosed Xcell Biosciences round closed in January 2022 at Series B.
We update the Xcell Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Francisco and their backers are listed below.
